Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NRX Pharmaceuticals Inc/
Recent news which mentions NRX Pharmaceuticals Inc/
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
Tags
NRX Pharmaceuticals Inc/
Baudax Bio Inc/
Cabaletta Bio Inc/
From
Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
March 10, 2023
Tickers
INNO
Tags
John Karanicolas
NRX Pharmaceuticals Inc/
Sanjay S/ Subramanian
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
Inno
Health Care
AnPac Bio/Medical Science Co/ Ltd/
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Passage Bio Inc/
Inno
Health Care
From
Business Journals
NRx Pharmaceuticals on search for new CEO
March 09, 2022
Tags
Jonathan Javitt
Coronavirus
Biotech
From
Business Journals
Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
January 07, 2022
Tickers
INNO
Tags
Annovis Bio Inc/
Temple University
Health Care
From
Business Journals
NRx Pharmaceuticals takes second shot a getting emergency use approval for Covid-19 treatment
January 05, 2022
Tags
Pharmaceuticals
Jonathan Javitt
Coronavirus
From
Business Journals
Lab Notes: Penn Medicine's $14M NIH grant; NRx seeks designation for drug candidate
December 30, 2021
Tickers
INNO
Tags
Hospitals
Johnson & Johnson
Ali Naji
From
Business Journals
NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug
November 29, 2021
Tags
Pharmaceuticals
Jonathan Javitt
Biotech
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.